Samuel A Funt Selected Research

Samuel A Funt Research Topics

Disease

26	Neoplasms (Cancer) 01/2024 - 07/2016
11	Carcinoma (Carcinomatosis) 11/2023 - 01/2017
8	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 09/2023 - 07/2016
6	Urinary Bladder Neoplasms (Bladder Cancer) 10/2023 - 01/2017
3	Neoplasm Metastasis (Metastasis) 01/2024 - 01/2021
3	Inflammation (Inflammations) 10/2023 - 07/2011
3	Melanoma (Melanoma, Malignant) 01/2023 - 11/2014
2	Extramammary Paget Disease (Paget Disease, Extramammary) 04/2024 - 01/2021
2	Seminoma 01/2024 - 01/2018
2	Small Cell Carcinoma 10/2022 - 01/2021
2	Disease Progression 12/2021 - 01/2021
2	Teratoma (Teratoid Tumor) 01/2021 - 10/2019
2	Breast Neoplasms (Breast Cancer) 08/2020 - 01/2016
1	Ototoxicity 09/2023
1	Hearing Loss (Hearing Impairment) 09/2023
1	Histiocytosis 01/2023
1	Dysgerminoma 01/2023
1	Testicular Neoplasms (Testicular Cancer) 01/2023
1	Virus Diseases (Viral Diseases) 01/2023
1	Lung Neoplasms (Lung Cancer) 01/2022
1	Human Influenza (Influenza) 01/2022
1	Urachal adenocarcinoma 01/2022
1	Necrosis 01/2021
1	Microsatellite Instability 01/2021
1	Thoracic Diseases 01/2021
1	Exanthema (Rash) 08/2020
1	Non-Muscle Invasive Bladder Neoplasms 01/2018
1	Multiple Myeloma 01/2018
1	Pathologic Complete Response 01/2016
1	Hypertension (High Blood Pressure) 03/2015
1	Atherosclerosis 07/2011
1	Pathologic Constriction (Stenosis) 07/2011
1	Weight Gain 07/2011

Drug/Important Bio-Agent (IBA)

9	Immune Checkpoint InhibitorsIBA 11/2023 - 01/2019
8	Biomarkers (Surrogate Marker)IBA 11/2023 - 01/2020
5	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 07/2016
3	RNA (Ribonucleic Acid)IBA 10/2023 - 01/2017
3	Tumor Biomarkers (Tumor Markers)IBA 01/2023 - 07/2016
3	B7-H1 AntigenIBA 01/2022 - 01/2017
3	PlatinumIBA 05/2021 - 10/2019
2	Carboplatin (JM8)FDA LinkGeneric 09/2023 - 01/2018
2	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 10/2020
2	atezolizumabIBA 01/2022 - 01/2017
2	Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA 05/2021 - 12/2020
2	NivolumabIBA 01/2021 - 01/2018
2	IpilimumabIBA 01/2021 - 11/2014
2	Etoposide (VP 16)FDA LinkGeneric 01/2021 - 01/2020
2	ElementsIBA 10/2019 - 04/2018
2	Angiotensin IIIBA 03/2015 - 07/2011
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 03/2015 - 07/2011
1	erdafitinibIBA 11/2023
1	interleukin-21 (interleukin 21)IBA 01/2023
1	pembrolizumabIBA 01/2023
1	EpitopesIBA 01/2023
1	AntigensIBA 01/2023
1	Interleukin-2 (IL2)IBA 01/2023
1	CytokinesIBA 01/2023
1	Transcription Factors (Transcription Factor)IBA 11/2022
1	Gemcitabine FDA Link 01/2022
1	MicroRNAs (MicroRNA)IBA 01/2022
1	Brentuximab VedotinIBA 12/2021
1	tremelimumabIBA 01/2021
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2021
1	durvalumabIBA 01/2021
1	Blocking AntibodiesIBA 01/2021
1	Cell-Free Nucleic AcidsIBA 01/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 08/2020
1	AlpelisibIBA 08/2020
1	Histamine H1 AntagonistsIBA 08/2020
1	cyclopropapyrroloindoleIBA 01/2020
1	AntibodiesIBA 01/2019
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2017
1	pertuzumabIBA 01/2016
1	Proteins (Proteins, Gene)FDA Link 03/2015
1	Apolipoproteins E (ApoE)IBA 07/2011
1	Superoxides (Superoxide)IBA 07/2011
1	Protein Isoforms (Isoforms)IBA 07/2011
1	ApolipoproteinsIBA 07/2011
1	Interleukin-17 (Interleukin 17)IBA 07/2011

Therapy/Procedure

16	Therapeutics 04/2024 - 01/2017
12	Drug Therapy (Chemotherapy) 01/2024 - 07/2016
11	Immunotherapy 01/2024 - 01/2017
3	Aftercare (After-Treatment) 01/2023 - 01/2017
3	Neoadjuvant Therapy 10/2022 - 12/2020
2	Lymph Node Excision (Lymph Node Dissection) 01/2024 - 01/2020
2	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2023 - 01/2020
2	Adjuvant Chemotherapy 10/2022 - 01/2020
2	Cystectomy 10/2022 - 01/2022
1	Hearing Aids (Hearing Aid) 09/2023
1	Duration of Therapy 01/2023
1	Chemoradiotherapy 10/2022
1	Metastasectomy 01/2021
1	Salvage Therapy 01/2021
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 03/2015
1	Ligation 07/2011